Showing 121 - 140 results of 412 for search '"CYP1A2"', query time: 1.97s Refine Results
  1. 121

    Thyme and Oregano Oil Potential Therapeutics against Malathion Toxicity through Biochemical, Histological, and Cytochrome P450 1A2 Activities in Male Wistar Rats by Fatimah A. Al-Saeed, Montaser Elsayed Ali

    Published 2024-10-01
    “…However, the results indicated that TEO was more effective than OEO in increasing CYP1A2 expression and alleviating MOP-induced toxicity. …”
    Get full text
    Article
  2. 122

    In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions by Parthena Martin, Maciej Czerwiński, Pallavi B. Limaye, Seema Muranjan, Brian W. Ogilvie, Steven Smith, Brooks Boyd

    Published 2022-06-01
    “…Incubation of nFFA with rCYP1A2, rCYP2B6, rCYP2C19, and rCYP2D6 resulted in 10%−20% metabolism and no clear inhibition of nFFA metabolism by any CYP‐selective inhibitor. …”
    Get full text
    Article
  3. 123

    Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes by Li Zhuo-Rong, Yi Hong, Li Ying-Hong, Wang Yue-Ming, Yang Peng, Kong Wei-Jia, Wang Yan-Xiang, Ren Gang, Li Yi, Song Dan-Qing, Jiang Jian-Dong

    Published 2011-05-01
    “…In the cell-free transformation reactions, M2 and M3 were detectable after incubating BBR with rCYP450s or human liver microsomes; however, M1 and M4 were below detective level. CYP2D6 and CYP1A2 played a major role in transforming BBR into M2; CYP2D6, CYP1A2 and CYP3A4 were for M3 production. …”
    Get full text
    Article
  4. 124

    Bioactivation, Mutagenicity, DNA Damage, and Oxidative Stress Induced by 3,4-Dimethylaniline by Mariam R. Habil, Raúl A. Salazar-González, Mark A. Doll, David W. Hein

    Published 2024-12-01
    “…In CHO cells expressing CYP1A2 and NAT1, 3,4-DMA caused concentration-dependent increases in reactive oxygen species (ROS), double-stranded DNA damage, and HPRT mutations. …”
    Get full text
    Article
  5. 125
  6. 126
  7. 127

    Evaluation of the inhibition performance of pyrrole derivatives against CYP450 isoforms by Magdalena Kondeva-Burdina, Emilio Mateev, Ali Irfan, Hristina Kuteva, Maya Georgieva

    Published 2024-05-01
    “…The aim of this study was to conduct in silico and in vitro activity assessments of recently synthesized pyrrole-based compounds against three major CYP450 isoforms – CYP1A2, CYP2D6 and CYP3A4. The in vitro study contained specific cytochrome P450 isoform inhibitors and substrates (for CYP1A2, CYP2D6, and CYP3A4) to determine the inhibition performance of the tile compounds at 1 µM concentration. …”
    Get full text
    Article
  8. 128

    Safety issues regarding melatonin use in child and adolescent patients with sleep problems by Eunsoo Moon, Jung Hyun Lee

    Published 2022-12-01
    “…It is necessary to monitor potential drug interactions with medications such as inhibitors and enhancers of cytochrome P450 1A2 (CYP1A2). Furthermore, low CYP1A2 expression in young children requires proper dose adjustment. …”
    Get full text
    Article
  9. 129

    代谢活化系统在人细胞转化模型中的应用

    Published 2009-01-01
    “…【目的】 探讨不同的代谢活化系统在人细胞转化模型中潜在的应用价值65377; 【方法】 在永生化人肝细胞L02中导入第12密码子突变的H-RAS癌基因(L02-R细胞),使其处于恶性转化前的易感状态65377;选择具有代表性的间接致癌物黄曲霉毒素B1 (aflatoxin B1, AFB1) 作用于永生化和转化前期细胞株,采用三种代谢系统:高表达代谢酶P450 CYP1A2,低剂量底物诱导和加入经典的大鼠S9代谢辅助系统,通过软琼脂克隆形成试验和裸鼠皮下成瘤试验来比较在不同的代谢活化系统下,间接致癌物诱导细胞转化的效能65377; 【结果】 蛋白印迹验证H-Ras稳定高表达的转基因细胞株构建成功65377;通过Ames试验,蛋白印记和CYP1A2酶活性等方法比较三种代谢系统酶活性65377;在未加代谢系统的条件下,经AFB1染毒后第17周L02-R细胞发生转化,而对照组细胞L02-V在染毒20周未能发生转化65377;而加入S9代谢系统时,AFB1诱导L02-R细胞在第8周发生转化,比未加代谢系统缩短了9周;经低剂量0.1 μmol/L AFB1诱导和高表达CYP1A2均使L02-R的转化间期缩短6周,于第11周发生转化65377; 【结论】 三种代谢系统都能够促进间接致癌物AFB1的代谢活化,缩短细胞转化的时间,提高细胞转化效率65377;与传统的S9代谢活化系统相比,低剂量诱导作为新的代谢活化的方法在细胞转化试验中有着良好的应用前景65377;…”
    Get full text
    Article
  10. 130

    The Reduction of the Combined Effects of Aflatoxin and Ochratoxin A in Piglet Livers and Kidneys by Dietary Antioxidants by Roua Gabriela Popescu, Sorin Avramescu, Daniela Eliza Marin, Ionelia Țăranu, Sergiu Emil Georgescu, Anca Dinischiotu

    Published 2021-09-01
    “…The purpose of this study was to investigate the combined effects of aflatoxin B1 and ochratoxin A on protein expression and catalytic activities of CYP1A2, CYP2E1, CYP3A29 and GSTA1 and the preventive effect of dietary byproduct antioxidants administration against these mycotoxin damage. …”
    Get full text
    Article
  11. 131

    Effects of Chronic Alcohol Intake on the Composition of the Ensemble of Drug-Metabolizing Enzymes and Transporters in the Human Liver by Kari A. Gaither, Guihua Yue, Dilip Kumar Singh, Julia Trudeau, Kannapiran Ponraj, Nadezhda Y. Davydova, Philip Lazarus, Dmitri R. Davydov, Bhagwat Prasad

    Published 2025-01-01
    “…Tobacco smokers showed elevated CYP1A2, UGT1A6, and UGT2B4 and reduced FMO3, FMO4, and FMO5 levels, while in females, CYP1A2, UGT2B17, and UGT2B15 levels were lower, and UGT2A3 and STS were higher compared to males. …”
    Get full text
    Article
  12. 132

    Dietary Resveratrol Alleviates AFB1-Induced Ileum Damage in Ducks via the Nrf2 and NF-κB/NLRP3 Signaling Pathways and CYP1A1/2 Expressions by Hao Yang, Yingjie Wang, Chunting Yu, Yihan Jiao, Ruoshi Zhang, Sanjun Jin, Xingjun Feng

    Published 2022-01-01
    “…The expression of genes, including CYP1A2, CYP2A6, and CYP3A4, at the mRNA level was significantly upregulated (<i>p</i> < 0.05) by AFB<sub>1</sub>. …”
    Get full text
    Article
  13. 133

    Inhibitory effects of herbal medicines with claimed anticancer indications on cytochrome P450—An evaluation of drug-herb interactions risk by Misheck Mudyiwa, Manju Sharma, Samarendra Kumar Ray, Collen Masimirembwa, Roslyn Stella Thelingwani

    Published 2023-09-01
    “…Drugs that are substrates of CYP1A2 should be administered with caution for patients who are taking the herbs which have been studied in this research as risk for drug toxicities may be high. …”
    Get full text
    Article
  14. 134

    Mertansine Inhibits mRNA Expression and Enzyme Activities of Cytochrome P450s and Uridine 5′-Diphospho-Glucuronosyltransferases in Human Hepatocytes and Liver Microsomes by Won-Gu Choi, Ria Park, Dong Kyun Kim, Yongho Shin, Yong-Yeon Cho, Hye Suk Lee

    Published 2020-03-01
    “…A 48 h treatment of mertansine (1.25&#8722;2500 nM) in human hepatocytes resulted in the dose-dependent suppression of mRNA levels of CYP1A2, CYP2B6, CYP3A4, CYP2C8, CYP2C9, CYP2C19, UGT1A1, and UGT1A9, with IC<sub>50</sub> values of 93.7 109.1, 36.8 18.3, 160.6 167.4, 32.1 14.9, 578.4 452.0, 539.5 233.4, 856.7 781.9, and 54.1 29.1 nM, respectively, and decreased the activities of CYP1A2-mediated phenacetin <i>O</i>-deethylase, CYP2B6-mediated bupropion hydroxylase, and CYP3A4-mediated midazolam 1-hydroxylase. …”
    Get full text
    Article
  15. 135

    In Vitro Inhibitory Effects of Scutellarin on Six Human/Rat Cytochrome P450 Enzymes and P-glycoprotein by Yong-Long Han, Dan Li, Quan-Jun Yang, Zhi-Yong Zhou, Li-Ya Liu, Bin Li, Jin Lu, Cheng Guo

    Published 2014-05-01
    “…In this study, the in vitro inhibitory effects of scutellarin on six major human CYPs (CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4) and six rat CYPs (CYP1A2, CYP2C7, CYP2C11, CYP2C79, CYP2D4, and CYP3A2) activities were examined by using liquid chromatography-tandem mass spectrometry. …”
    Get full text
    Article
  16. 136

    Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia by Estela Sangüesa, Emilio Fernández-Egea, Julia Concha, Cristina B. García, María Pilar Ribate

    Published 2024-03-01
    “…Genetic associations were explored, highlighting <i>SLC6A4, HTR2A</i>, and the *1F/*1F polymorphism for the <i>CYP1A2</i> gene.…”
    Get full text
    Article
  17. 137

    Effect of Honokiol on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes by Yong Yeon Cho, Jae Young Lee, Jun-Ho Choi, Sung Hum Yeon, Sung-Woon Hong, Soon Sang Kwon, Tae Yeon Kong, Hyeon-Uk Jeong, Hye Suk Lee

    Published 2013-09-01
    “…These in vitro results indicate that honokiol has the potential to cause pharmacokinetic drug interactions with other co-administered drugs metabolized by CYP1A2, CYP2C8, CYP2C9, CYP2C19, and UGT1A9.…”
    Get full text
    Article
  18. 138

    Gene Silencing and Haploinsufficiency of Csk Increase Blood Pressure. by Hyeon-Ju Lee, Ji-One Kang, Sung-Moon Kim, Su-Min Ji, So-Yon Park, Marina E Kim, Baigalmaa Jigden, Ji Eun Lim, Sue-Yun Hwang, Young-Ho Lee, Bermseok Oh

    Published 2016-01-01
    “…Injection of siRNAs for mouse homologs Csk, Ulk3, and Cyp1a2 (negative control) showed reduced target gene mRNA levels in vivo. …”
    Get full text
    Article
  19. 139

    Sex differences in CYP450-based sodium dehydroacetate metabolism and its metabolites in rats by Meng Zhang, Pengfei Du, Yirong Xiao, Hao Liu, Meixue Wang, Yumei Zhang, Xin Chen

    Published 2024-12-01
    “…Here, we identified several Cytochrome P450 (CYP450) sub-enzymes involved in sex differences related to DHA-Na metabolism, along with two related DHA-Na metabolites. CYP1A2, CYP3A2, and CYP2D1 were primarily responsible for DHA-Na metabolism, which was stronger in male rats than in female rats. …”
    Get full text
    Article
  20. 140

    استخلاص الكافئين ومستقلبه الباراكزانيتن من البول ومقايستهما بواسطة جهاز الكروموتوغرافيا السائلة عالية الأداء... by د. سمر الزير

    Published 2023-08-01
    “…يستقلب الكافئين بواسطة أنزيم السيتوكروم CYP1A2 إلى مستقلبه الأساسي الباراكزانيتن. هدف هذا البحث إلى دراسة مصدوقية طريقة استخلاص وتحليل الكافئين والباراكزانتين معاً في البول بواسطة جهاز الكروموتوغرافيا السائلة عالية الأداء HPLC كونه جهاز متوافر. …”
    Get full text
    Article